| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/21/2013 | WO2013024074A1 Plasminogen and plasmin variants |
| 02/21/2013 | WO2013024043A2 In vivo screening models for treatment of qc-related disorders |
| 02/21/2013 | WO2013023992A1 Guard cell-specific expression of transgenes in cotton |
| 02/21/2013 | WO2013023878A1 Pichia ciferrii cells and use thereof |
| 02/21/2013 | WO2013023852A1 Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in alzheimer's and vascular dementia |
| 02/21/2013 | WO2013023763A1 Bitransgenic bovine |
| 02/21/2013 | WO2013006861A9 Sorghum grain shattering gene and uses thereof in altering seed dispersal |
| 02/21/2013 | WO2013006547A9 Antibodies against epidermal growth factor receptor (egfr) and uses thereof |
| 02/21/2013 | WO2013006050A9 Peptides inducing or enhancing an immune response against prostate-specific membrane protein (psma) |
| 02/21/2013 | WO2013003449A3 Methods of treatment with glp-1 receptor agonists |
| 02/21/2013 | WO2012176115A3 Plants having enhanced yield-related traits and a method for making the same |
| 02/21/2013 | WO2012172427A3 Peptide compounds for inhibition of platelet aggregation |
| 02/21/2013 | WO2011091305A3 Inhibition of axl signaling in anti-metastatic therapy |
| 02/21/2013 | US20130047299 Defensin-Encoding Nucleic Acid Molecules Derived From Nicotiana Alata, Uses Therefor And Transgenic Plants Comprising Same |
| 02/21/2013 | US20130046056 Chromatography matrices including novel staphylococcus aureus protein a based ligands |
| 02/21/2013 | US20130045923 Collagenous material |
| 02/21/2013 | US20130045537 Methods and compositions relating to multiciliate cell differentiation |
| 02/21/2013 | US20130045518 Variant sucrose transporter polypeptides that enable faster sucrose utilization in bacteria |
| 02/21/2013 | US20130045488 Benzocyanine compounds |
| 02/21/2013 | US20130045480 Novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes - useful or detection or quantification of desirable target molecules |
| 02/21/2013 | US20130045479 Methods for evaluating the stage of ovarian cancer or the survival rate of an ovarian cancer patient |
| 02/21/2013 | US20130045270 Method of use of stabilized growth factor in skin care |
| 02/21/2013 | US20130045233 Novel Allergen |
| 02/21/2013 | US20130045230 Composition containing hcmv particles |
| 02/21/2013 | US20130045225 Synthetic Antigen Based on the Ligand Domain of the Plasmodium vivax Duffy Binding Protein |
| 02/21/2013 | US20130045224 Immunostimulatory compositions and methods of use thereof |
| 02/21/2013 | US20130045221 T-cell receptor capable of recognising an antigen from cytomegalovirus |
| 02/21/2013 | US20130045212 Biological Materials and Uses Thereof |
| 02/21/2013 | US20130045191 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
| 02/21/2013 | US20130045181 Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease |
| 02/21/2013 | US20130045180 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2013 | US20130045176 Stable peptide-particle adduct compositions with improved surface adhesion |
| 02/21/2013 | US20130045171 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 02/21/2013 | CA2846240A1 Antibodies that bind integrin alpha-v beta-8 |
| 02/21/2013 | CA2845266A1 Methods for extracting keratin proteins |
| 02/21/2013 | CA2844644A1 Plasminogen and plasmin variants |
| 02/20/2013 | EP2559766A1 Plants modified for reduced cadmium transport, derivative products, and related methods |
| 02/20/2013 | EP2559763A1 HLA-binding peptides, precursors thereof, DNA fragments and recombinant vectors that code for those peptide sequences |
| 02/20/2013 | EP2559760A1 Ischemic disorder-promoting polypeptide |
| 02/20/2013 | EP2559754A2 Method for producing an L-amino acid using a bacterium of the family enterobacteriaceae having enhanced expression of the flagella formation and motility cascade genes |
| 02/20/2013 | EP2559701A1 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 02/20/2013 | EP2559700A2 Compositions and methods of using proislet peptides and analogs thereof |
| 02/20/2013 | EP2559699A1 Plants having improved growth characteristics under reduced nutrient availability and a method for making the same |
| 02/20/2013 | EP2559698A2 Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies |
| 02/20/2013 | EP2558576A1 Hairless nod scid mouse |
| 02/20/2013 | EP2558574A1 Use of endogenous promoters to express heterologous proteins |
| 02/20/2013 | EP2558503A1 Compositions and methods for brain delivery of analgesic peptides |
| 02/20/2013 | EP2558498A2 Antibodies that bind human cd27 and uses thereof |
| 02/20/2013 | EP2558491A1 Fibronectin based scaffold domain proteins that bind pcsk9 |
| 02/20/2013 | EP2558490A1 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors |
| 02/20/2013 | EP2558489A1 Robo1-fc fusion protein and use thereof for treating tumours |
| 02/20/2013 | EP2558488A1 Banana lectins and uses thereof |
| 02/20/2013 | EP2558487A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease |
| 02/20/2013 | EP2558486A1 Antigenic structure and uses thereof for screening trypanosomiases in humans and animals |
| 02/20/2013 | EP2558485A1 Antigenic polypeptides of trichinella and uses thereof |
| 02/20/2013 | EP2558484A1 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 02/20/2013 | EP2558483A1 Polyacetylenic compounds with anti-fungal activity derived from the bacterium collimonas and methods for the preparation and identification thereof |
| 02/20/2013 | EP2558482A1 Engineered plant cysteine proteases and their uses |
| 02/20/2013 | EP2558481A1 Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same |
| 02/20/2013 | EP2558480A1 Promoter for regulation of gene expression in plant roots |
| 02/20/2013 | EP2558137A1 Methods and combination |
| 02/20/2013 | EP2558118A1 Cross-protecting vaccine for porcine reproductive and respiratory syndrome virus |
| 02/20/2013 | CN102939384A Genes conferring stress tolerance in plants and uses thereof |
| 02/20/2013 | CN102939383A Methods and compositions for targeted polynucleotide modification |
| 02/20/2013 | CN102939304A Albumin derivatives and variants |
| 02/20/2013 | CN102939303A Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 02/20/2013 | CN102939302A Method |
| 02/20/2013 | CN102939299A Purification of blood coagulation factors |
| 02/20/2013 | CN102939110A Selective modification of proteins |
| 02/20/2013 | CN102939103A Influenza virus vaccines and uses thereof |
| 02/20/2013 | CN102939102A Recombinant multimeric influenza proteins |
| 02/20/2013 | CN102939099A Treating allergy with detoxified e. coli heat-labile enterotoxin |
| 02/20/2013 | CN102936604A Human hcrcn81 pronucleus recombinant plasmid, protein and rabbit anti-human polyclonal antibody expressed by same and application |
| 02/20/2013 | CN102936602A Recombinant human insulin-like growth factor-2 protein and production method thereof |
| 02/20/2013 | CN102936283A Anti-human CD146 monoclonal antibodies, compositions containing anti-human CD146 monoclonal antibodies, and soluble CD146 detection method |
| 02/20/2013 | CN102936282A Gall-stone removing compound and application thereof |
| 02/20/2013 | CN102936281A RTRAIL(recombinant TNF(tumor necrosis factor) related apoptosis-inducing ligand) mutant and monomethyl auristatin E(MMAE) conjugate thereof |
| 02/20/2013 | CN102936280A Extraction and purification method of phosvitin in eggs |
| 02/20/2013 | CN102936279A Plant somatic embryogenesis gap-associated protein GhSERK2 as well as encoding gene and application thereof |
| 02/20/2013 | CN102295699B Process for purifying cytochrome C |
| 02/20/2013 | CN102229662B Lotus annexin and expression vector and application thereof |
| 02/20/2013 | CN102220346B Antioxidation-related genes of wheat as well as coding proteins thereof and application thereof |
| 02/20/2013 | CN102153637B Wild soybean LEAFY transcription factor and coding gene and application of wild soybean LEAFY transcription factor |
| 02/20/2013 | CN101701219B cDNA for encoding rabbit hepatocyte growth factor and expression vector and application thereof |
| 02/19/2013 | USRE44024 Isolation and characterization of ECA1, a gene overexpressed in endometroid carcinomas of ovary and endometrium |
| 02/19/2013 | USRE44022 Cyclic peptides, method for preparing and use as angiogenesis inhibitors or activators |
| 02/19/2013 | US8378171 Plant regulatory sequences for selective control of gene expression |
| 02/19/2013 | US8378169 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 02/19/2013 | US8378084 Fusion molecule based on novel TAA variant |
| 02/19/2013 | US8378079 Antibody to human zcyto-10 polypeptide |
| 02/19/2013 | US8378078 Diagnosis of Whipple's disease |
| 02/19/2013 | US8378077 Fluorescent protein |
| 02/19/2013 | US8378075 Covalent attachment of peptides and biological molecules to luminescent semiconductor nanocrystals |
| 02/19/2013 | US8378074 High affinity HIV T cell receptors |
| 02/19/2013 | US8378071 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| 02/19/2013 | US8378069 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 02/19/2013 | US8378068 Apolipoprotein A-I mimics |
| 02/19/2013 | US8378066 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
| 02/19/2013 | US8378064 Hydrophilic polymers as medical lubricants and gels |